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ABSTRACT
Silver nanoparticles (AgNPs) have attracted tremendous attention as a potential broad-
spectrum antimicrobial agent to overcome multidrug resistant (MDR) infections. However, 
a comprehensive understanding to AgNPs bactericidal mechanism of action and the 
relative role of particulate versus ionic Ag in AgNPs antibacterial activity is lacking but 
essential for their optimization for potential medical applications. Therefore, a novel 
method to separate and quantify Ag internalization in P. aeruginosa was developed and 
validated through multimethod approach. The methods used were optical density at 600 
nm (OD600), LIVE/DEAD staining, transmission electron microscopy (TEM), and sorbed 
Ag liberation assays. After optimizing the method, it was applied to quantify Ag content 
in different bacterial fractions. To better understand the dynamic transformations of AgNPs 
upon exposure and the relative bioavailability/biouptake of different Ag species, bimetallic 
Au@Ag NPs was used and Ag:Au ratios were calculated in different bacterial 
compartments. Results showed a nearly constant OD600 within the first two hours of 50 
mM EDTA treatment indicating complete bacterial growth cessation. However, bacterial 
density declined beyond this treatment condition indicating cell lysis. LIVE/DEAD 
staining images indicated intact bacterial membrane before- and after- EDTA treatment for 
six hours. Cell counts observed in untreated controls were statistically similar to cell counts 
after two hours exposure to EDTA. Whereas significantly (p <0.0001) fewer cells were 
observed in images after six hours EDTA exposure when compared to untreated controls. 
This suggested that complete disruption and lyses of cells may have occurred upon EDTA 
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exposures exceeding two hours rather than the simple cell membrane damage or/and 
increased permeability. TEM results indicated intact, smooth, and dense cell boundaries 
for untreated controls and cells exposed to EDTA for two hours. No membrane 
disintegrations were detected even after six hours EDTA treatment, but cells featured very 
light and thin surfaces near the cell edges compared to control. However, 50 mM EDTA 
treatment is a very high concentration and is expected to remove most of the periplasm. 
The plateau obtained in the Ag liberation curve, from the operationally defined sorbed 
fraction, within the first two hours of EDTA treatment suggested complete removal of 
sorbed Ag. Whereas the statistically significant (p <0.05) increase in Ag mass content after 
six hours EDTA treatment was likely as a result of cells lysis and/or increased membrane 
permeability. The weight of evidence across the multimethod approach suggested that two 
hours of EDTA treatment at a concentration of 50 mM provided a reproducible estimation 
of Ag uptake in the operationally defined internalized fraction approximating the accurate 
value in the Gram-negative bacterium P. aeruginosa. Therefore, this method was applied 
to quantify metallic distribution upon exposing bacteria to Au@Ag NPs. Ag distribution 
data indicated that the total Ag accumulated in the abiotic phase was mostly in dissolved 
form and was 45.5% and 54.8 % for 0.2 mg L-1 and 2.0 mg L-1 Au@Ag NPs exposure, 
respectively. The external cellular fractions after periplasm removal were 42.2% for 0.2 
mg L-1 Au@Ag NPs exposure whereas for 2.0 mg L-1 Au@Ag NPs exposure it was 44.7%. 
The internalized fraction accumulated 16.2% ± 1.8 in 2.0 mg L-1 Au@Ag NPs exposure 
that was significantly greater (p = 0.0066) than 9.9% ± 1.1 in 0.2 mg L-1 Au@Ag NPs 
exposure. On the other hand, molar ratios were significantly greater consistently in all 
biotic phase fractions at lower exposure concentration except for internalized fraction. 
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Molar ratios detected in both abiotic phase (p >0.9999) and internalized fractions (p 
=0.9999) were not significantly different from pristine NPs. Ag:Au ratios indicated a 
significant concentration-dependent effect on Ag transformations and bioavailability. At 
higher exposure concentration, Ag was less bioavailable (in both external and internalized 
cellular fractions), and aggregation appeared to be the dominant process. In contrast, Ag 
was more bioavailable, and dissolution seemed to be the dominant process at lower 
exposure concentration. The weight of evidence suggests that Ag+ preferentially adsorbed 
to the external cellular surface, whereas a complex mixture of depleted original Au@Ag 
NPs and dissolved Ag in either ionic or secondary NPs forms accumulated in the 
internalized fraction. However, these fractions were operationally defined and might not 
perfectly match their corresponding theoretical definitions. Consistent with previous 
studies, our results suggest that both AgNPs and dissolved Ag are bioavailable to bacterial 
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CHAPTER 1 





1.1 INTRODUCTION  
Nanotechnology is a multidisciplinary scientific field that is currently bringing 
revolutionary advances across wide array of fields including medicine, medical 
technology, engineering, electronics, and many others [1-3]. “There’s plenty of room at the 
bottom” titled Richard Feynman his famous lecture, in which he explained the potential of 
nanotechnology in a wide range of scientific fields by tailoring material properties at the 
atomic scale [4].  
 Nanoparticles (NPs) are the building blocks for the rapidly growing field of 
nanotechnology [5]. NPs are wide class of materials and typically defined to be of diameter 
range from 1 to 100 nm in at least one dimension [6]. At this size scale, materials can 
demonstrate novel properties compared to their bulk counterparts [7]. For instance, NPs 
tend to exhibit high chemical reactivity and unique optical properties that are attributed to 
the electronic confinement effects and the larger specific surface area (i.e., surface area per 
unit mass) [8-10]. Consequently, NPs are attracting scientific community in a plethora of 
novel applications and research opportunities in a vast range of fields [11]. 
 NPs are in the size scale of biological molecules [12] and can be produced with 
certain properties to fulfill certain intended functions [13] and therefore, they are 
potentially useful for medical applications [14]. Utilizing NPs unique properties for the 
purpose of diagnosing and treating health conditions is known as nanomedicine [15]. It is 
considered a relatively new area of nanotechnology that has demonstrated several high-
quality benefits, and promises numerous medical advancement such as enhancing drug 
delivery and efficiency [16, 17], overcoming multidrug resistance (MDR) [18], enabling 
early detection of diseases [19], and improving imaging technology [20]. 
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 Nanotechnology exploits NPs tunable properties in designing highly functional 
agents with diagnostic and therapeutic capabilities [21]. Among those, NPs-based bacterial 
detection and treatment of bacterial-related conditions. In this review, various medical 
applications involving NPs-bacteria interactions and the current approaches available to 
study these interactions will be discussed. However, a key aspect of understanding these 
interactions is to understand bacterial envelope structure. 
1.2 BACTERIAL CELL ENVELOPE 
 
Bacteria are single-celled microorganisms that lack a nucleus and membrane-bound 
organelles. However, they possess highly sophisticated and multilayered structure (Figure 
1.1). Typically, they fall into one of two main categories according to their cell envelope 
[22]. In both groups, cytoplasmic (i.e. plasma) membrane is surrounded by a rigid 
protective barrier layer that is the peptidoglycan cell wall (CW). In Gram-positive bacteria, 
this layer is relatively thick (10-20 nm), while in Gram-negative bacteria the CW is much 
thinner (2-7 nm) and is surrounded by an additional outer membrane layer that is a 
distinctive feature of Gram-negative bacteria [23]. The outer membrane is a lipid bilayer 
and is mainly composed of phospholipid from the inside whereas the outside leaflet is 
mainly composed of lipopolysaccharide (LPS). LPS molecules are cross-linked by divalent 
cations, mainly Ca2+ and Mg2+, which is essential to outer membrane integrity [24]. 
 The organization and composition of these multilayers are crucial determinants of 
bacterial interaction dynamics with various external factors [25, 26]. Bacterial cell 
envelope plays key roles in maintaining cells structure, controlling passage of molecules, 
and performing many other vital regulatory and physiological functions [27]. Primarily, 
the envelope serves as an efficient protective barrier against a wide range of  physical, 
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chemical, and biological threats including antibiotics [28]. Along with cell envelope, 
bacteria have multiple strategies to ensure their survival against antibiotics called resistance 
mechanisms. Understanding those mechanisms is crucial for the imperative demand to 
developing agents to overcome MDR [29]. 
1.3 BACTERIAL RESISTANCE MECHANISMS 
Bacteria typically develop multiple resistance mechanisms (Figure 1.2) that can be 
classified into two major categories: 1) intrinsic and 2) acquired resistance. These 
mechanisms include the use of enzymes to inactivate antibiotics, altering antibiotics uptake 
through efflux pumps or decreasing membrane permeability, modifying the antibiotics’ 
cellular target (i.e., receptor sites), developing alternative metabolic pathways, biofilm 
formation, and transferring resistance gene among microbial community, [30-32]. 
Bacterial genetic plasticity (e.g. chromosomal mutation, acquiring R plasmid, and 
transposons) allows them to cope and survive various modes of action of antimicrobial 
agents [33]. Natural selection favors resistance cells which then disseminate resistance 
traits across bacterial populations [34] vertically by replication of bacterial genetic material 
during cell division [35] and/or horizontally through genes exchange within bacterial 
population [36]. 
 To enhance their resistance, the vast majority of actively functioning bacteria do 
not exist as individual isolated planktonic cells as it was traditionally believed but rather, 
they predominantly exist in an attached biofilm state [37]. This results in formation of 
metabolically integrated microbial communities [38] existing within a protective platform 
that facilitates cell-cell signaling and resistance genes transfer [39, 40]. Biofilms slow the 
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diffusion and penetration of antimicrobial agents and provide means for the bacterial 
community to inactivate antibiotics [41]. 
 Conventional antibiotics affect bacterial viability through limited mechanisms 
(Figure 1.2) that are preventing regeneration of cell wall, interfering with cell membrane 
integrity and permeability, inhibiting nucleic acid synthesis, perturbing metabolic activity, 
and interfering with protein synthesis [42]. However, bacteria are highly adaptive 
organisms, and have found ways to ensure their survival. These adaptations result in the 
development of MDR bacterial infections, which pose serious public health threats [43]. It 
has therefore become urgently needed to develop alternative antimicrobial agents with 
novel modes of action to treat MDR infections [44].  
1.4 NPs’ MECHANISMS OF ANTIMICROBIAL ACTIVITY 
Unlike conventional antibiotics, it is believed that NPs tackle bacteria through multiple 
mechanisms simultaneously and overwhelm bacterial resistance mechanisms [45]. 
Although NPs antibacterial activity is highly promising, the exact mechanism is poorly 
understood [46-49]. Many metal-based NPs exhibit potent biocidal activity through 
multiple mechanisms (Figure 1.3) [30, 50]. Recently, the growing interest of incorporating 
NPs into medical applications has led to an increasing demand for elucidating the NPs 
underlying modes of antibacterial action [51]. Table 1.1 and table 1.2 summarize 
antibacterial potencies and antimicrobial mechanisms of selected nanoparticles. A 
thorough understanding regarding the mechanisms of interaction between bacteria and NPs 
at the cellular level is lacking but is essential for the successful development of NPs 
applications in the medical field. Such data will be very useful in directing NPs 
optimization for potential medical applications [52-54].  
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 In certain instances, NPs exert their antibacterial activity through direct physical 
contact with the bacterial cell. Researchers have suggested numerous forms of contact 
including receptor-ligand interactions [55], van der Waals forces [56], electrostatic 
attractions [57], and hydrophobic interactions [58]. NPs may also make their way into the 
inside of bacterial cells where they can perturb essential structural components [59], alter 
genetic expression, and disturb biological functions [60-62]. On the other hand, several 
reports attributed NPs antibacterial activity largely to being sustained reservoirs for 
continuous release of ions [63, 64]. However, the most commonly suggested mechanisms 
of NPs antibacterial activity are as follows. 
1.4.1 ROS Production 
Reactive oxidant species (ROS) are a natural byproduct of cellular metabolic activity and 
play a key role in cell homeostasis [65]. Excess ROS are generated as metallic NPs interact 
with bacteria leading to oxidative stress [66]. The rate of ROS generation is highly 
dependent on the NPs physicochemical characteristic such as size and coating [67] as well 
as on the exposure media contents and conditions such as pH [68]. Numerous biologically 
significant ROS could be generated including superoxide (O2•–), singlet oxygen (1O2), 
hydroxyl (HO•), and hydroperoxyl (HO2•) ions [65, 69]. 
 Several reports attributed engineered NPs toxicity in a wide range of 
microorganisms mainly to their capability of ROS generation [70]. Arakha and his 
colleagues examined the antimicrobial activity of iron oxide NPs (FeONPs) with two 
different coatings, they found that FeONPs that generated higher ROS was associated with 
more potent antimicrobial activity against E. coli and Bacillus subtilis [71]. Similarly, 
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silver NPs (AgNPs) antimicrobial activity have been also demonstrated to be associated 
with ROS generation [72]. 
1.4.2 Interaction with Cytoplasmic Components 
Many metal-based NPs exert their biocidal effect through interacting with the internal 
cellular components of bacteria, in both metallic and ionic forms [73]. The antibacterial 
activity of AgNPs, zinc oxide NPs (ZnONPs), and copper oxide NPs (CuONPs) [74] have 
been demonstrated toward a broad spectrum of bacterial strains [75-78]. Metallic NPs 
might release dissolved ions as they come in contact with the exposure medium [30, 79]. 
Free ions have been found to readily cross cell membranes and perturb vital physiological 
processes [80, 81]. Several cytoplasmic targets for NPs have been suggested including 
disruption of bacterial gene expression [82] and protein synthesis [83]. Furthermore, it has 
been shown that these NPs perturb cell wall permeability and lead eventually to leakage of 
cytoplasmic contents [84]. 
1.4.3 Sorption and Penetration through Barriers 
Interaction kinetics by which NPs kill bacteria remain poorly understood. This is especially 
true for the bacterial uptake of NPs and whether or not this involves their internalization 
[30]. Several studies suggested NPs accumulation and deposition over bacterial surface 
[85-88]. Other reports demonstrated evidence suggesting NPs penetration and 
internalization into bacterial cytoplasm [89-92]. NPs internalization might be preceded by 
NPs surface sorption that perturb membranes permeability [86]. In fact, it was found that, 
NPs’ capability to adhere to a cell surface is directly proportional to their uptake efficiency 
[93]. For example, quantum dots (QDs) found to be readily adsorbed to the surfaces of both 
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Gram-positive and Gram-negative bacteria probably due to electrostatic forces followed 
by internalization [94].  
A recent study demonstrated the internalization of ZnONPs and titanium dioxide 
NPs (TiO2NPs) into the cytoplasm of the Gram-negative bacterium Salmonella 
typhimurium [95]. A research group studied AgNPs mechanisms of antimicrobial activity 
against E. coli and found formation of “pits” in the bacterial cell wall. These pits were 
suggestive of AgNPs creating holes in the membrane to penetrate and destroy bacterial 
cells [83]. Several studies addressed adsorption of AuNPs over the outer bacterial surface 
during interaction between AuNPs and bacteria [96, 97]. However, in-depth understanding 
to the antibacterial mechanisms of NPs is yet to be elucidated [85, 98]. Although multi-
modal mechanisms were proposed to be involved in NPs antibacterial activity [63, 99-101], 
developing clear understanding is crucial particularly for NPs potential medical application 
[102]. 
1.5 NPS MEDICAL APPLICATIONS 
While some NP-based medical applications are already in use, several applications are still 
in the research and development phase and are yet to be clinically approved [103, 104]. For 
instance, only one NPs, namely iron oxide NPs (FeONPs), have been approved and 
currently in use for diagnostic purposes in clinical practice [105]. Whereas the vast 
majority of NPs-based therapeutic applications that are currently undergoing clinical trials, 
are NPs-based formulations to enhance the activity of previously approved drugs [106]. 
The difficulty in clinically approve NPs-based formulations may be attributed to the 
tedious and tremendously challenging approval process for new drugs [107]. Granting a 
clinical approval requires extensive and comprehensive preclinical steps including 
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conducting extensive research, using appropriate design of clinical trials, and successfully 
completing all these clinical trials [108, 109].  
 NPs offers a highly versatile multifunctional platform in which potential dual 
applications of same NP can be achieved [110, 111]. For instance, positively charged silver 
shelled gold core-shell NPs (Au@Ag NPs) tend to aggregate on the surface of negatively 
charged bacteria, which make them of greater medical use. Au@Ag core-shell NPs 
exhibited both potent antimicrobial activity against Staphylococcus aureus and enhanced 
two-photon photoluminescence effect [112], which make them suitable for theranostic 
applications (i.e., therapeutic and diagnostic). Similarly, QDs, which are fluorescent 
nanocrystals, tend to have high affinities for cellular proteins and could be functionalized 
for both bacterial detection and treatment [94, 113].  
 On the other hand, researchers are currently developing new NPs-based protease 
sensors that concurrently distinguish bacterial from other forms of lung infection and 
monitor the effectiveness of prescribed antibiotic [114]. This technique enables identifying 
the nature of causative agent, and hence avoiding unnecessary administration of antibiotics 
that might potentially contributes to MDR [115]. Additionally, it enables monitoring the 
effectiveness of the drug which allow for “course correction” and implementation of an 
alternative effective therapeutic plan [116, 117]. This multifunctionality is projected to 
potentially revolutionize the current approach in diseases management for a wide variety 
of health conditions. In this section, various potential medical applications of NPs in 




1.5.1 Therapeutic Applications  
1.5.1.1 NPs as Antimicrobials 
Over the last years, treatment and control of infectious diseases have been achieved 
predominantly through antibiotics administration [118, 119]. However, bacterial versatility 
along with misuse of antibiotics have contributed to the emergence of MDR [120]. 
Recently, NPs exhibited promising antibacterial potential toward multiple MDR strains 
[121]. Certain NPs have novel intrinsic antimicrobial activity and have been studied 
extensively. Among all NPs, AgNPs were the most studied for potential use against MDR 
infections [122].  
Numerous studies have been conducted to evaluate the bactericidal effect of AgNPs 
against major MDR strains, including those termed the ESKAPE pathogens [123]. 
ESKAPE is an acronym for six serious and clinically important human pathogens that 
exhibit MDR properties: Enterococcus faecium, Staphylococcus aureus, Klebsiella 
pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa (P. aeruginosa), 
and Enterobacter spp. [124]. AgNPs are found to be effective as potential broad-spectrum 
antibiotics against both Gram-negative and Gram-positive bacteria [125].  
 Furthermore, NPs are being studied for their antibiofilm activities and have been 
incorporated to prevent biofilm formation and nosocomial device-associated infections 
[126, 127]. Metal and metal oxide NPs, such as AgNPs, ZnONPs, CuONPs, FeONPs, and 
many others are exhibiting inherent toxicity to microorganisms at concentrations lower 
than those are toxic to human cells, and therefore can be applied for this purposes [50, 128]. 
For example, ZnONPs and AgNPs have been widely used as broad spectrum anti-biofilm 
agents for coating implants and medical devices [129-131]. Topical applications of AgNPs 
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in wound dressings hastened the healing process of wounds and resulted in a better 
cosmetic appearance when applied to animal models [132]. 
1.5.1.2 Drug Delivery 
Traditional medical treatment strategies carry many pitfalls that can be improved upon by 
modern technological advances and strategies. For instance, administration of non-targeted 
drugs requires using higher doses in order to have the adequate concentration received at 
the target site(s) [133, 134]. Cytotoxic side effects of non-targeted drugs are usually more 
severe and occur more frequently when compared with targeted drugs [135]. Limited drug 
bioavailability remains a further significant drawback of non-targeted therapeutic 
strategies [136]. Therefore, targeted therapeutic approaches are more desirable as they can 
increase drug efficiency and minimize cytotoxicity.  
Targeted drug delivery provides controlled, long-lasting release of specific drugs 
at specific sites [134, 137, 138]. NPs are particularly useful in drug delivery due to their 
high specific surface area, which confers them the capability to adsorb and bind multiple 
molecules [139]. Interestingly, NPs were engineered not to carry medications only, but to 
bind cell membrane penetrating agents, and stimulus-sensitive agents. As a result, NP are 
planned to carry more than one treatment, deliver it specifically to the target where a 
stimulus could be applied, such as ultraviolet or infrared irradiations for photosensitive 
agents, to stimulate drug release [140]. This therapeutic approach will enhance specificity, 
efficacy, and minimize toxicity of the drug [141]. Drug accumulation around target sites 
increases their efficiency and subsequently improves drug safety by improving their 
resulting therapeutic index [142, 143]. 
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 NPs are also employed as vehicles for the efficient delivery of vaccines [144]. For 
example, silica NPs, a biocompatible non-degradable form of NP, have been structured and 
fine-tuned for the purpose of immune engineering in vaccine formulation [145]. 
Furthermore, NPs were designed to potentiate and/or manipulate immune cells for specific 
immune responses by modulating an important group of immune cells called antigen 
presenting cells [146]. NPs-based drug delivery holds promising potential to considerably 
advance therapeutic healthcare strategies in preventing and controlling a wide range of 
infectious diseases [147, 148].  
1.5.2 Diagnostic Applications 
NPs-based diagnostic modalities in the medical field are projected to vastly enhance 
healthcare through enabling early detection of diseases and providing means for rapid, 
sensitive, and minimally invasive testing [149-151]. Rapid screening tests allow physicians 
to diagnose and initiate treatment plans immediately at point-of-care [152]. Early, 
sensitive, and specific detection plays an essential role in controlling the spread of 
infectious diseases [153]. Furthermore, diseases detected at early stages usually have 
higher chances for successful treatment and better prognosis [154-156]. Therefore, 
incorporating these techniques into medical diagnostic practice will contribute to an overall 
improvement of healthcare systems and public health. 
NPs are set to be a powerful diagnostic tool as they can be fine-tuned through 
manipulating their physiochemical properties such as diameter, coating, and concentration 
[157]. NPs enhance the sensitivity of certain diagnostic modalities by labelling specific 
cellular components [158]. AuNPs, in particular, possess a unique plasmon resonance 
properties which make them excellent for fluorescent-based labelling that can be detected 
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by numerous fluorescence techniques [159, 160]. Additionally, they have been 
demonstrated as a very useful contrast agent in photoacoustic imaging (i.e., a type of 
imaging that utilizes both optical and acoustic imaging) [161]. Greatly amplified 
photoacoustic signals and better images with higher contrast were achieved by modifying 
AuNPs coating from polyethylene glycol (PEG) to silica [162]. Furthermore, their surface 
is relatively easily functionalized with various targeting agents to monitor or localize 
specific biological targets [163].  
Several other NPs have shown promising features that might be potentially translated 
into clinical application such as QDs [164], silica NPs [165], and FeONPs [166]. Recently, 
these NPs and many others integrated with various imaging and bacterial detection 
techniques resulted in faster and improved sensitivity of bacterial identification. In fact, 
certain approaches are capable of highly efficient and simultaneous detection of multiple 
biomarkers within relatively short amount of time [150]. However, all these are still in the 
developing phase and are being tested for their reproducibility and safety. 
1.6 BIOAVAILABILITY AND BIOUPTAKE 
Biouptake of NPs in bacteria depends mainly on the bioavailability (biological availability) 
of NPs in the exposure medium [167]. The bioavailable portion of a given material is the 
fraction that is available to be taken up by a certain organism under a defined set of 
conditions [168]. Considering factors affecting NPs bioavailability in exposure media 
cannot be overlooked in toxicity and biouptake studies. For the purpose of this dissertation, 
we will focus on factors influencing AgNPs bioavailability. 
 Exposure media tend to have complex chemical compositions that influence AgNPs 
bioavailability [169-171]. Bioavailability has a key role in dictating the bactericidal activity 
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of AgNPs. Greater bioavailability is presumed to correlate with enhanced antibacterial 
activity and vice versa [172, 173]. AgNPs biocidal activity is strongly influenced by 
dynamic physical, biochemical transformation and speciation in exposure media. 
Therefore, understanding the factors affecting bacterial bioavailability and biouptake of 
AgNPs is crucial to their applications in the medical field [172].  
 Factors influencing AgNPs bioavailability can be grouped into two main 
categories: 1) initial physicochemical characteristics of the AgNPs such as size, capping 
agent, dispersion, and concentration [174] and 2)  chemical composition of the system 
where exposure is taking place including pH, ionic strength, protein, and electrolyte 
contents) [175, 176]. 
 Dispersed and smaller AgNPs tend to remain in the aqueous phase and have a 
higher mobility than larger, agglomerated AgNPs, which tend to settle down and therefore 
become less bioavailable [172]. Sterically stabilized AgNPs (e.g., PVP-coated) generally 
feature higher colloidal stability than electrostatically stabilized AgNPs (e.g. citrate-
coated) in terms of both aggregation and dissolution [177]. Both dissolution and 
aggregation of AgNPs are concentration dependent processes. The presence of AgNPs at 
high concentrations increases their potential to aggregate whereas they tend to be in 
dissolution-dominant regime at low exposure concentrations [178, 179]. Dissolved Ag 
might reprecipitate to form secondary NPs or speciate to another form of Ag compounds 
such as silver-chloro- (Ag-Cl) complexes [179]. Furthermore, NPs biouptake is a 
morphology and size-dependent process. Smaller as well as spherical NPs are more likely 
to efficiently penetrate into cells compared to larger and differently shaped NPs [180-182]. 
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 Ionic strength and pH of experimental media will also influence the colloidal 
stability of AgNPs. Lower pH and higher ionic strength are associated with increased rates 
of aggregation especially in electrostatically stabilized AgNPs [175, 183]. AgNPs interact 
readily with proteins and electrolytes and therefore their presence in culture media should 
be considered [175]. Ag ions (Ag+) has very high affinity to bind chloride (Cl-) and form 
Ag-Cl complexes, which alter the bioavailability and bactericidal activity of Ag [184]. 
AgNPs instantly acquire a protein layer in protein-rich exposure media called protein 
corona. Formation of protein corona modifies AgNPs surface characteristics and 
consequently their antimicrobial activity [185]. 
1.7 CURRENT APPROACHES TO INVESTIGATE INTERACTIONS BETWEEN 
BACTERIA AND NPs 
 
Interactions of NPs with bacteria are quite complex and controversial in the literature. It is 
widely believed that multiple interactions take place simultaneously [30, 45] including cell 
wall adhesion, internalization, and oxidative stress, resulting ultimately in perturbing 
vitally essential functional and structural components [186]. To date, interactions of NPs 
with bacteria are poorly understood especially from mechanistic perspectives [98]. Studies 
usually provide partial or limited information due to the complexity of interactions in 
exposure systems and inability of available techniques to quantify such interactions  [46, 
187, 188]. However, understanding the interactions is crucial for assessing the NPs risks 
and benefits for potential medical applications [189]. In this section, current techniques 
used to evaluate underlying mechanisms involved in bacteria-NPs interaction will be 
discussed. Several assays have been used to assess interactions, which can be classified 
into two major categories: 1) toxicokinetic (TK) and 2) toxicodynamic (TD) approach. 
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1.7.1 Toxicokinetic Approach 
In the TK approach, interactions are typically analyzed by high-resolution imaging 
techniques, which can provide direct and quantitative essential information about NPs and 
cells such as proximity, penetration, and aggregation [190, 191]. These techniques include, 
but are not limited to, transmission electron microscopy (TEM) [192], scanning electron 
microscopy (SEM), energy‐dispersive X‐ray spectroscopy (EDX) [193], conventional 
fluorescent microscopy, confocal laser scanning microscopy (CLSM) [61], nuclear 
magnetic resonance (NMR) [150], flow cytometry [192], and reflection-based imaging 
[194, 195].  
 Imaging technologies help localize NPs at the cellular level and determine whether 
the interactions involved NP sorption to bacterial cell walls and/or internalization. 
Concurrently, these tools help to simultaneously characterize structural changes in bacteria 
as well as morphological changes in NPs upon exposure. However, these techniques have 
certain limitations. For example, TEM examinations require that specimens are dehydrated 
then observed in a vacuum, which may introduce artifacts leading to misinterpretation of 
data [196]. Sample fixation, dehydration and embedding are essential steps in TEM sample 
preparation, which hinder the possibility of monitoring interaction on living cells [197]. 
EDX, which is a multi-elemental analysis technique that generate characteristic peaks 
indicative of element presence in tested specimens [198], detection limits may 
underestimate NPs composition in different cellular compartments [199]. For all these 
techniques, data can only be partially obtained as investigators can only analyze a limited 
areas of the sample due to time and cost constraints [196, 200]. Furthermore, real-time 
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monitoring and analysis of actual biological interactions usually obscured as images are 
not taken directly from environment where NPs and bacteria co-occur [201]. 
In addition to imaging techniques, quantitative multielement information with high 
precision capacity and low detection limit are obtained from spectroscopic analytical 
techniques, which are becoming dominant source of NPs-bacteria interaction data [202, 
203]. These techniques include inductively coupled plasma optical emission spectrometry 
(ICPOES) [204] and inductively coupled plasma mass spectrometry (ICPMS) [205]. More 
detailed information about the interactions (i.e., inferences on the presence of NPs in 
different bacterial compartments) are obtained when combined with separation techniques 
such as ultrafiltration and centrifugation [200]. Although mass analytical tools are widely 
used, they have some limitations such as an inability to distinguish particles from ions, 
difficult sample preparation, and elemental interference [206]. However, operating ICPMS 
in a single particle mode (SP-ICPMS) could overcome some of these limitations. SP-
ICPMS is a powerful tool that enables the distinguishing among elements in particulate 
and ionic forms using relatively simple requirements [207-209]. 
1.7.2 Toxicodynamic Approach 
The TD approach tend to assess toxicity of NPs to bacteria by determining their 
antimicrobial activity in term of bacteriostatic and bactericidal effect. Toxicity are usually 
investigated by viability-based [210] and growth-based [211] assay techniques. Key 
information may be obtained by comparing cells before and after treatment or against 
controls. These tools include absorbance measurements at 600 nm (OD600) [212], disc 
diffusion assays [213], broth dilution assays, time-kill tests, plate count methods, TEM  
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[214], and fluorescent-based imaging (such as CLSM and flow cytometry) coupled with 
two-color fluorescent stain (LIVE/DEAD staining kit) [215, 216]. 
 The LIVE/DEAD BacLight stain kit is composed of equal combinations of nucleic 
acid stains SYTO9 and propidium iodide (PI). SYTO9 fluoresces green and penetrates into 
all cells due to its relatively small molecular size and surface charge. Whereas PI, which is 
relatively larger in molecular size, fluoresces red and is only able to penetrate cells with 
compromised membranes where it will displace the green fluorescence. These differences 
allow easy microscopical assessment of bacterial viability as a function of cell membrane 
integrity where intact cells appear green whereas compromised cells appear red in color 
[217, 218].  
 Antimicrobial susceptibility assays are usually conducted using standardized 
protocols in accordance with two main institutions: the Clinical and Laboratory Standards 
Institute (CLSI) and the European Committee on Antimicrobial Susceptibility Testing 
(EUCAST) [219]. Methodologies for testing should be standardized as outcomes of 
susceptibility testing are greatly influenced by type of culture media, inoculum density, 
incubation conditions such as temperature and speed of agitation, and other components of 
experiments [220]. Essential toxicity data obtained through a toxicodynamic approach such 
as minimum inhibitory concentration (MIC) and minimum bactericidal concentration 
(MBC). 
 Antimicrobial assays have been routinely used in microbiology to assess the 
bacteriostatic and bactericidal properties of drugs. However, there are certain drawbacks 
to these techniques. For example, determining the best therapeutic concentration is not 
attainable using dilution method as it does not compare antimicrobial potencies, and it is 
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designed to only determine MIC and MBC [221]. Cell membrane integrity could be 
induced during sample processing when assessing cell viability with TEM [222]. OD600 
absorbances do not directly measure bacterial densities but rather measures bacterial 
suspension turbidity through detection of light scattering and absorbance at 600 nm. Thus, 
OD600 measurements are only a rough estimate of bacterial density and can be easily 
affected by bacterial suspension matrices [223]. Plate counting method allow only a 
relatively narrow range for the limit of quantification (25-250 CFU/plate) [224]. 
Additionally, the assumption that a single colony was founded by single viable microbial 
cell is not always correct and may underestimate the actual microbial density [225]. 
1.8 DISSERTATION OVERVIEW 
Although nanotechnology hold a promising potential in counteracting MDR bacterial 
infections, a comprehensive understanding to the mechanism(s) of interaction is lacking, 
but mandatory to optimize their use in medical applications. However, this appeared to be 
quite intricate given the lack of standardized methodology and analytical techniques to 
quantify such a complex interaction. Therefore, the overall aim of this dissertation was to 
develop a chemical extraction method to separate and quantify the internalized and sorbed 
fractions of Ag to the surface of selected Gram-negative bacterium P. aeruginosa. 
 A method employing novel application of EDTA to separate surface sorbed from 
truly internalized Ag was developed and validated. EDTA is a chelating agent with high 
affinity to divalent cations that stabilize bacterial outer membrane. We hypothesized that, 
under appropriate treatment conditions, EDTA will specifically remove the periplasm 
along with sorbed Ag and separate it from the internalized Ag without significantly 
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affecting inner membrane integrity. To validate this, four different analytical and imaging 
techniques were used, to investigate the effect of different EDTA treatment conditions. 
 To better understand the dynamic AgNPs transformations and their influence on 
NPs bioavailability and biouptake, the previously validated method was applied after 
exposing bacteria to bimetallic Au@Ag NPs. These NPs are particularly useful because 
they have Au core that is protected from direct interactions with exposure media and 
remains in particulate form throughout exposure duration. Therefore, it could be used as 
an internal standard for this study purpose. We hypothesized that bacteria take up (i.e., 
internalize) the dissolved Ag from AgNPs. To test this hypothesis, metallic molar ratios 
were calculated and analyzed in abiotic and biotic phases in different bacterial fractions. 
 The ultimate goal of this dissertation is to provide a well validated method to 
separate and quantify the internalized fraction of Ag. Furthermore, to provide insights on 
the influence of AgNPs dynamic transformations in the exposure media on NPs 
bioavailability and biouptake.  
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type Size (nm) Organism MIC/MBC References 
Silver 20-25 
P. aeruginosa ATCC 
27853 
 
E. coli ATCC 25922 
 
S. aureus ATCC 
25923 
 
MIC = 0.4 µg/mL 
 
 
MIC = 0.5 µg/mL 
 
 
MIC = 0.7 µg/mL 
[226] 
Zinc oxide 
9.5 S. mutants MIC = 4 µg/mL [227] 
19 E. coli MIC = 50 µg/mL [228] 
Titanium 
dioxide 
250–300 P. aeruginosa ATCC 27853 MIC = 20 µg/mL [229] 














MIC50 =< 1 µg/mL 
 
MIC50 =10 µg/mL 
[231] 
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Nanoparticle type Antimicrobial mechanism 
Silver -Perturb cell membrane permeability and integrity [83, 84]. 
-Alter genetic material [82, 84]. 
-ROS generation [72]. 
-Disrupt protein synthesis [83]. 
-Antibiofilm activity [227]. 
Zinc oxide -Interfere with cell membrane [232]. 
-ROS generation [233]. 
-Internalize into bacteria [95] 
- Release of Zn2+ [234] 
Titanium dioxide -Cell membrane disruption [235]. 
-Produce ROS [236]. 
Copper Oxide -Produce ROS [230]. 
-Cell membrane damage [237]. 
-Antibiofilm activity [238]. 
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Figure 1.1 Schematic representation of bacterial cell envelopes of Gram-positive and -






Figure 1.2 Schematic representation for conventional antibiotics cellular targets and 













Figure 1.3 Diagram showing several proposed antimicrobial mechanisms of selected 





DEVELOPING AND VALIDATING A NOVEL PROTOCOL TO 
SEPARATE AND QUANTIFY THE INTERNALIZED FRACTION OF 





Multidrug resistance (MDR) is an emerging significant public health issue that is 
associated with increased mortality, morbidity, and healthcare costs. Silver nanoparticles 
(AgNPs) is regarded as a potential broad-spectrum antimicrobial agent against MDR 
infections. However, the exact mechanism(s) of AgNPs antimicrobial activity is yet to be 
fully elucidated. Although there are many studies on Ag biouptake, quantitative data 
remain limited. In the present study, a method using EDTA to separate truly cellular 
internalized fraction of Ag was developed and validated. EDTA is a chelating agent that 
disrupt bacterial periplasm by binding to divalent cations that maintain outer membrane 
integrity. Accordingly, it is expected to specifically remove the periplasm and leave cell 
inner membrane intact under appropriate treatment conditions. This method was validated 
through multimethod approach. The result showed that, 50 mM EDTA Inhibited bacterial 
growth during the first 2 hours of treatment. However, evidence of cell lysis beyond these 
conditions were observed. OD600 data indicated decreased cells density at longer exposure 
duration and higher EDTA concentrations. Confocal micrographs showed significantly 
fewer cell counts (p <0.001) after six hours EDTA exposure suggesting significant 
influence on bacterial viability. Furthermore, TEM images showed thin cell surfaces near 
edges compared to two hours EDTA exposure. Ag liberation curve showed a plateau within 
the first two hours of exposure to 50 mM EDTA while significantly higher Ag masses were 
observed beyond that (p <0.05) likely due to increased permeability or cells rupture. 
Therefore, 50 mM EDTA for two hours suggested the complete removal of outer 
membrane while preserving viable cells reproducibly and consistently across the 
multimethod approach. Based on the weight of evidence, this method is reliable to be 
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utilized for its stated purpose. By using this method, accurate approximation to the 
estimated internalized cellular fraction of Ag in Gram-negative bacterium P. aeruginosa 
can be obtained. 
2.2 INTRODUCTION 
Antimicrobial agents have been helpful in combating bacterial infections since their 
discovery in 1920s [120]. However, a significant proportion of human pathogenic bacteria 
have developed MDR owing to misuse as well as overuse of antibiotics. This represents an 
emerging major public health concern that is resulting in increased severities of infections, 
prolonged hospital stays, increased mortality [122, 124] and limited treatment options for 
infected individuals [241]. It is estimated that 50,000 lives are lost in the United States and 
Europe only [242] and at least 700,000 lives across the world each year [241] due to MDR 
infections. Therefore, there is an urgent demand for developing new antimicrobials with 
new modes of actions [243-245]. 
 Recently, NPs received attention as a potential future treatment against MDR 
pathogens [246]. AgNPs, particularly, are considered the most promising of all NPs due to 
their broad-spectrum and potent antimicrobial activity [247]. Silver (Ag) has been used 
widely as antimicrobial for thousands of years [248]. More recently, AgNPs are attracting 
substantial interest in the medical field as a new class of antimicrobial agents [122, 249] 
that bacteria are less likely to develop resistance against [250]. AgNPs have been 
incorporated into many medical applications such as wound dressings [251] and coatings 
to implanted devices [252]. Although the antimicrobial activities of AgNPs has been 
extensively studied, the exact mechanism is not yet fully understood [253, 254]. A 
thorough understanding regarding the mechanism(s) of interaction between bacteria and 
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AgNPs at the cellular level (e.g. biouptake processes) is lacking [246, 255] but essential 
for the successful development of AgNPs in potential medical applications. [255, 256]. 
 The complex interaction between AgNPs and bacteria have been widely studied 
[257-259]. Biouptake mechanisms have been suggested to involve (strong or weak) 
sorption onto the bacterial cell surface [83], and/or intracellular compartmentalization [82]. 
The outer portion of a Gram-negative bacterial cell, called the periplasm, is the space 
between the outer cell membrane and the inner plasma membrane. The inner plasma 
membrane represents the barrier to differentiate between the uptake of NPs into the 
bacterial cytoplasm, and those that are outside of this border [22]. Measurements of AgNPs 
at different cellular compartments will enhance our understanding to bacterial uptake 
processes of AgNPs. 
 To our knowledge, no standard method to date applied to Ag allowing such 
differentiation. Therefore, the aim of this study was to develop a methodology to quantify 
AgNPs internalization into the Gram-negative bacterium, P. aeruginosa. In this project, a 
chemical extraction method was successfully developed and data differentiating the 
cellular internalized portion, and externally sorbed fraction were reported. The results will 
provide very useful methodology to help better understand biouptake processes involved 
in NPs-bacteria interaction.  
2.3 MATERIALS AND METHODS 
2.3.1 AgNPs synthesis and characterization 
AgNPs were synthesized using a standard chemical reduction method of silver nitrate 
(AgNO3 Sigma-Aldrich; CAS No. 7761-88-8) by sodium borohydride (NaBH4; Alfa 
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Aesar; Cat. No. 88983) in the presence of the capping agent, trisodium citrate (TSC; VWR; 
CAS No. BDH0288), following slight modifications to a previously established and 
standard procedures [260]. Briefly, solutions of 1.7 mL AgNO3 (0.25 mM), 2.9 mL TSC 
(0.31 mM), and 1 mL NaBH4 (0.25 mM) were prepared using ultrapure water (UPW; 18.2 
MΩ-cm). 400 mL of UPW was heated to boiling in a conical flask with vigorous stirring. 
AgNO3 and TSC were added simultaneously to the boiling water and mixed for an 
additional three minutes. Then, 0.5 mL of NaBH4 was slowly added to the mixture in a 
drop-wise manner at the rate of one drop (~15 uL) every five seconds. Finally, the mixture 
was further heated while stirring vigorously for 30 minutes and then allowed to cool in 
darkness at room temperature (25 °C) overnight. 
 The synthesized batch was washed three times to remove excess unreacted reagents 
and ions using diafiltration (Amicon; 3 kDa regenerated cellulose membrane; Millipore). 
Nanoparticles were resuspended in TSC solution to avoid dryness and formation of 
secondary nanoparticles. To enhance NPs stability, an aliquot of the citrate coated AgNPs 
was further coated with polyvinylpyrrolidone (PVP) by adding PVP10 (Mw 10,000; Sigma 
Aldrich; CAS Number 9003-39-8) while stirring in darkness for one hour. The number of 
PVP molecules needed to cover the entire nanoparticles is calculated to be eight molecules 
per nm2 [261, 262].  
 Stock AgNPs were comprehensively characterized using multimethod approach. 
The mean z-average diameter and polydispersity index (PDI) were obtained by replicate 
measurements using dynamic light scattering (DLS) (Malvern Instruments, MA, USA).  
Ultraviolet and visible light (UV–vis) spectra were measured in triplicate over the 
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wavelength range of 200-800 nm using a UV-Vis spectrophotometer (UV-2600, Shimadzu 
Co., Kyoto, Japan). Zeta potential, a measure of colloidal stability, was measured by laser 
Doppler electrophoresis (Malvern Zetasizer NanoZS, MA, USA). AgNPs TEM images 
were collected using Hitachi HT7800 TEM. Samples were prepared by ultracentrifugation 
of AgNPs suspension on a copper grid at 30,000 (150,000 x g) rpm for one hour at 4 °C 
[263] in Sorvall MTX 150 micro-ultracentrifuge (Thermo Scientific) with an S52-ST rotor. 
Size and size distribution were analyzed with the National Institutes of Health (NIH) 
ImageJ Version 1.46r software (https://imagej.nih.gov/ij/) package. 
2.3.2 Antibacterial activity 
To prepare bacterial cells for experiments, P. aeruginosa (ATCC 27853) was cultured in 
tryptic soy broth (TSB) media and incubated at 37 °C with shaking at 180 rpm. AgNPs 
antibacterial activities against P. aeruginosa were investigated using the broth 
microdilution assay [264] to identify the MIC. Briefly, P. aeruginosa stock culture was 
inoculated into sterile TSB medium and incubated at 37 °C with shaking. OD600 of 
microbial suspensions was measured and adjusted at 0.1 equivalents to 0.5 McFarland 
standard and diluted to 1 X 106 CFU/mL. Antibacterial activities of citrate coated AgNPs 
(Cit-AgNPs) and PVP coated AgNPs (PVP-AgNPs) were tested in triplicate using sterile 
96-well microtiter plates. 100 uL of microbial suspension, combined with 100 uL of each 
type of Ag at the desired concentrations, were added to each well using sterile technique. 
Sterility controls (broth only; no bacterial inoculum) and growth controls (no Ag) were 
also applied. Then, 96-well plates were sealed with parafilm to prevent evaporation and 
were incubated (20 hours) in darkness at 37 °C with shaking (80 rpm). MIC values were 
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determined as the lowest concentration of Ag that was sufficient to prevent bacterial 
growth. 
2.3.3 Chemical extraction method validation  
The proposed chemical extraction method was validated using four different approaches: 
1) measurements of OD600 of bacterial suspension upon exposure to varying 
concentrations of ethylenediaminetetraacetic acid (EDTA) over time, 2) bacterial viability 
assays using CLSM, 3) structural change assays using TEM, and 4) sorbed Ag liberation 
assays using ICPMS. 
OD600 measurements were obtained as a quantitative measure of growth dynamics 
of bacterial cells under different EDTA concentration treatments. The optimum 
concentration of EDTA was determined to be the highest treatment concentration/duration 
that inhibited bacterial growth without impacting bacterial cell viability. Failure to inhibit 
growth indicated lower than needed concentration and vice versa. 
 Confocal micrographs were analyzed to assess the viability of bacterial cells in 
terms of cell membranes integrity. TEM was used to visualize changes in bacterial 
morphology and microstructures at different timepoints of EDTA treatments and to 
quantify internalized AgNPs, if any. At the optimal treatment conditions, EDTA will only 
remove the bacterial periplasm (i.e., outer cell membrane, cell wall, and molecules 
contained within this space) along with sorbed NPs, but will do so without influencing 
bacterial viability or leading to major structural changes.  
Finally, the Ag free/weakly bound fractions, sorbed fractions, and internalized 
fractions were separated (see section 2.4.4) and masses for each fraction were plotted 
against time. A plateau in sorbed fraction indicated release of all periplasm and surface 
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sorbed Ag. In contrast, an increased mass value indicated lysis of cells or increased 
permeability of the cell membranes. The details of these methods and their outcome are 
discussed further below. 
2.3.3.1 Optical density 
Initially, a rangefinder experiment was conducted to determine the optimum bacterial 
exposure conditions (concentration and exposure time) to EDTA that would remove the 
bacterial outer membrane and cell wall without influencing cell viability. Bacterial cultures 
were exposed to varied concentrations of EDTA, 20, 30, 50, 75 and 100 mM, in triplicate 
and the OD600 was monitored over time. Cells viability and the removal of outer 
membrane was further verified through imaging with CLSM and TEM.  
2.3.3.2 Bacterial viability assay 
Samples were collected after EDTA exposure at different timepoints (t): t1.5, t2 and t6 
hours, for both controls, and cells exposed to different forms of Ag (Cit-AgNPs, PVP-
AgNPs, and Ag+) and then stained using LIVE/DEAD BacLight bacterial viability kit and 
imaged with CLSM (Leica TCS SP5; HCX PL Apo 63×/ 1.40 oil-immersion objective) to 
determine the viability of cells over the different durations of exposure. Confocal images 
were further analyzed using ImageJ. At least five images were randomly taken for each 
timepoint and number of cells per field of view (FOV), which was 238x238 µm, were 
counted using “Analyze Particles” procedure [265]. Mean cell counts at each time point 
were compared using one-way analysis of variance (ANOVA). Where differences were 
significant, Tukey’s test was used for pairwise comparisons of the means at a significance 




2.3.3.3 Structural changes assay 
TEM images were obtained to verify the removal of bacterial outer membrane following 
EDTA treatment and to characterize detectable structural changes at the same timepoints. 
Samples were placed over 15 nm X 25 nm slot formvar-filmed copper grids (Ted Pella; 
Product # 01813-F) and were examined under TEM. When the desired treatment time was 
reached, a 1 mL sample was collected and washed three times by centrifugation (13,200 
rpm; 3 min.) to remove EDTA and other cellular residuals. Pellets were then resuspended 
in 0.5 ml phosphate-buffered saline (PBS) and 0.5 ml 4% paraformaldehyde for fixation 
and refrigerated at 4 °C in darkness. Following fixation, samples were washed three times 
and then resuspended in PBS. A small drop from each sample was placed over copper grids 
and allowed to air dry at room temperature and were examined by TEM. 
 To further investigate bacterial structural changes, samples were collected and fixed 
with 2% glutaraldehyde/2% paraformaldehyde in PBS. Ruthenium red (final conc. 0.1%) 
was added and samples agitated for one hour in darkness then rinsed with PBS to remove 
excess ruthenium red. Secondary fix were added with 2% osmium tetroxide (PBS) for three 
hours and agitated for three more hours in darkness then rinsed with water and embedded 
in 2% agar and thin sliced (<1 mm). The pellets were dehydrated through an ascending 
concentration series of ethanol and then embedded in polybed 812. Ultra-thin sections (~90 
nm thick) were obtained by ultramicrotome (Leica Ultracut R), placed over copper grids, 
stained with 1% uranyl acetate for 40 min and with Hanaichi's lead citrate for four minutes, 
and imaged with TEM [266]. EDX analyses were also performed to qualitatively test for 
the presence of Ag inside bacterial cells using ultra-high resolution scanning electron 
microscope (Hitachi SU9000) equipped with EDX.  
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2.3.3.4 Ag liberation curve 
Overnight P. aeruginosa cultures (15 hours) were harvested during late exponential growth 
phase (OD600=1.00 ± 0.2) by centrifugation (4,000 rpm for 10 min; 25 °C). Cells were 
washed then resuspended in fresh TSB. Bacterial suspensions were then exposed in 
separate containers to 2 mg L-1 from each form of Ag (Cit-AgNPs, PVP-AgNPs, and Ag+) 
in nutrient media (TSB) for 24 h in darkness under similar culture conditions. When the 
exposure time were completed, suspensions were washed three times by centrifugation 
under same conditions (Figure 2.1). Pellets were resuspended in PBS and treated with 50 
mM EDTA. Aliquots were taken from each sample at t1.5, t2, and t6 hours and washed by 
centrifugation three times (13,200 rpm; 3 min). This gave rise to three different fractions 
for each sample at each sampling timepoint as follows: 1) initial washes before treating 
with EDTA representing both free- and weakly-bound Ag to bacterial cells combined, 2) 
supernatant from washes after EDTA treatment representing the Ag fractions that were 
strongly sorbed to bacterial outer membranes and subsequently liberated by EDTA, and 3) 
pellets after EDTA treatment representing the assumed internalized fraction contained in 
the bacterial cytoplasm. 
 Finally, all samples were acidified with concentrated acid (70% HNO3) for 24 hours 
and then dilutions were made to a 1% HNO3 final concentration across all samples. Ag 
concentrations measured by ICPMS (Finnigan MAT, Germany). Results were statistically 







2.4.1 AgNPs characterization 
The synthesized batch of AgNPs was pale yellow in color. Table 2.1 summarizes the 
characteristics of synthesized batches. The increased hydrodynamic sizes obtained by DLS, 
and the shift in surface plasmon resonance (SPR) to longer wavelengths confirmed the 
conversion of AgNPs coatings from citrate to PVP [261] (Table 2.1).  Images obtained by 
TEM indicated that AgNPs were spherical in shape and the sample had a narrow size 
distribution (15.2 nm ± 3.5) (Figure 2.2). The total Ag concentration in the stock solution 
was 18.5 mg L-1 as determined by ICPMS measurements. 
2.4.2 Antibacterial activity 
The antimicrobial activities of both Cit-AgNPs and PVP-AgNPs toward P. aeruginosa 
were determined. Our results indicated stronger antibacterial activity was exhibited by Cit-
AgNPs. The MIC values were 5 mg L-1 and 7 mg L-1 for Cit-AgNPs and PVP-AgNPs, 
respectively. Therefore, 2 mg L-1 was selected as the sublethal dose to be applied to avoid 
the antibacterial effect of AgNPs for this study. 
2.4.3 Optical Density 
Effect of EDTA on bacterial growth was estimated using OD600. At concentration of 50 
mM, stable OD600 was observed during the first two hours indicating total inhibition of 
the growth. However, OD600 measurements was subsequently decreased beyond this 
exposure duration likely due to cell lysis (Figure 2.3). At exposure concentrations higher 
than 50 mM EDTA, the OD600 began to considerably decrease on or before the first one 
hour of exposure suggesting decreased number of viable cells. In contrast, increased 
 
37 
OD600 was observed for lower concentrations (<50 mM) indicating failure of bacterial 
growth inhibition by these EDTA concentrations. 
2.4.4 Bacterial viability assay 
Confocal cell imaging, for cells treated with LIVE/DEAD stain, visualized cells as green 
when their cell membrane integrity was maintained or as red otherwise. The results showed 
intact membranes for cells before- and after- exposure to EDTA for six hours (Figure 2.4). 
Although there was no detectable evidence for loss in membrane integrity, significantly 
fewer green cells (p <0.0001) were observed in images after six hours exposures when 
compared to untreated controls. No significant differences were found after two hours 
exposure (p =0.9656). Mean cell counts ± SD were 660 ± 43, 650 ± 35, and 306 ± 78 cells/ 
FOV for untreated control, exposed to EDTA at t2 hours, and t6 hours, respectively.   
2.4.5 Structural changes assay 
Cell pellets collected before, at t2 hours, and at t6 hours after EDTA exposure were 
analyzed using TEM. Similar results were observed for non-exposed controls and exposed 
after two hours of exposure (Figure 2.5). Cells had intact, dense, and smooth cell 
boundaries. Even after six hours exposure, cells were largely intact with no detectable 
lyses, but featured very light and thin surfaces near the cell edges compared to control. 
TEM thin sections analyses (Figure 2.6) showed no morphological changes in bacteria 
exposed to EDTA at t2 hours. In contrast, bacteria exposed to EDTA at t6 hours were 
unequally affected. Some cells showed irregular edges and relatively less dense cell walls.  
2.4.6 Ag liberation curve 
All Ag content detected in washes before EDTA treatment was considered as free/weakly 
bound Ag, while Ag detected in washes after EDTA treatment was considered as sorbed 
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fraction. All detected Ag in bacterial pellet was considered as the truly internalized fraction 
that was contained within the bacterial cytoplasm. Bacterial strains were exposed to 
sublethal doses of 2 mg L-1 for 24 hours then treated with EDTA. An Ag liberation curve 
was obtained by plotting Ag mass over time after EDTA treatment for sorbed fractions 
(Figure 2.7). 
 A mass balance for Ag was constructed for these data and recovery rates were 
calculated (Table 2.2). Free/weakly bound Ag was found to constitute about 24%, 33%, 
and 54% of the total exposure mass for Cit-AgNPs, PVP-AgNPs, and Ag+, respectively. In 
contrast, sorbed fractions ranged from 2% to 4% while internalized fractions ranged from 
12% to 37% from the total exposure mass in all types of Ag (Table 2.3). Statistically similar 
mass values were detected in first two hours of exposure to EDTA for both sorbed and 
internalized fractions for all types of Ag (Table 2.4). Whereas after six hours exposure, 
higher concentrations were detected in sorbed fractions while lower concentrations were 
detected in internalized fractions. 
2.5 DISCUSSION 
A novel chemical extraction method using EDTA for separating internalized and sorbed 
Ag was developed and validated through multi-laboratory analyses and imaging 
techniques. EDTA is a chelating agent that is known to sequester divalent cations, most 
especially calcium (Ca2+) and magnesium (Mg2+). These same ions bridge together LPS 
molecules in the outer membrane of Gram-negative bacteria [24]. Many studies of Gram-
negative bacteria, have demonstrated outer membrane disintegration and release of large 
quantities of LPS upon exposure to EDTA [24, 267-269]. Therefore, under appropriate 
conditions, EDTA is expected to completely remove the periplasm of P. aeruginosa along 
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with sorbed Ag without significantly impacting inner plasma membrane (i.e., phospholipid 
bilayer) [270].  
 Ideally, the appropriate treatment conditions for this study purpose would be the 
maximum EDTA concentration and exposure time under which complete cessation of 
bacterial growth is achieved without significant influence on bacterial cells survival. In this 
study, exposing P. aeruginosa to 50 mM EDTA temporally (i.e., within first two hours) 
inhibited cell division, likely due to stress-response pathway activation [271-273]. 
However, stress-response pathways seem to start failing and cells lysed beyond these 
exposure conditions (i.e., longer times and higher concentrations).  
 As indicated by confocal micrographs, bacterial membrane integrity and cell counts 
were preserved within first two hours of exposure compared to six hours exposure. While 
confocal images revealed no red cells, the significantly lower cell counts suggested that 
complete disruption and lyses of cells may have occurred upon EDTA exposures exceeding 
two hours rather than the simple cell membrane damage or/and increased permeability.  
These findings support our initial determination. 
 Thin and disrupted surfaces near cell membranes suggested that removal of the 
periplasm was occurring as indicated by TEM micrographs (Figure 2.5). This further 
supports the optical density measurements and CLSM results in showing that this method 
was working as proposed. Even though TEM images showed unequal EDTA impact on all 
cells, the 50 mM EDTA is a relatively high concentration and was expected to remove all 
sorbed Ag by weakening periplasm structures. Dense spherical particles were found inside 
cells (Figure 2.6), however, no Ag signals were detectable using EDX analyses. This could 
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be due to the low Ag concentrations of individual NPs, which are below the detection limits 
(of EDX) of 0.1% for total elements.  
 For practical considerations, we were able to show only two data points in the Ag 
liberation curve within the proposed maximum time for treatment. Both points showed 
statistically identical values and a resulting plateau was obtained (Figure 2.7). Although 
the plotted data did not produce an observable plateau for the suggested maximum 
treatment duration, the plateau obtained suggested that most sorbed Ag was liberated and 
separated from the internalized fractions. Two possible reasons might relate to the 
increased concentrations in sorbed fractions after applying EDTA for six hours, lysis of 
cells, or more likely increased permeability of the cell membranes. This conclusion is 
conducive to the known properties of EDTA as a permeabilizer, in addition to our finding 
here that bacteria still possessed intact membranes after six hours of exposure to EDTA. 
 Mass balance calculations after 24 h exposure to AgNPs indicated that Ag 
accumulated in all fractions (free/weakly bound, strongly sorbed to cell surface, and 
internalized). The highest fraction of Ag was the free/weakly bound which constituted up 
to 54% of total Ag. Whereas, sorbed Ag that was liberated by EDTA constituted only 4% 
at highest measurements (the lowest accumulating fraction). These data suggested that Ag 
multi-target mode of action against bacteria [30]. 
 The weight of evidence across the multimethod approach utilized in this study to 
validate the proposed method suggested that the method for periplasm removal in Gram-
negative bacterial cells was reliable and could be used for its stated purpose of 
differentiating Ag that was sorbed externally (weakly or strongly) vs that which was taken 
up by the (internal) cytoplasmic fraction. The consistency between results obtained by 
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optical density, TEM, CLSM, and ICPMS (Ag liberation curve) support our view that by 
using this method we are approximating the internalized fraction. Therefore, two hours of 
EDTA treatment at a concentration of 50 mM provided a reproducible estimation of 
internalized cellular fraction approximating the accurate value in the Gram-negative 
bacterium P. aeruginosa. However, the optimal exposure conditions may vary with 




Table 2.1 Summary of AgNPs physiochemical characterization data for pristine 



















   
 UV-vis absorbance 
 
DLS 
Sample Peak Position (nm) 
 









PVP-Coated 393.0 (1.0) 
 
34.1 (0.4) 0.2 (0.01) 
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Table 2.2 Recovery rates % for all types of Ag at different sampling timepoints obtained 
by ICPMS. Data represented as the sum of mean percent recovery (SD) from free/weakly 





(hours) Citrate-coated (%) PVP-coated (%) Ag
+ (%) 
1.5 75.2 (2.1) 67.8 (1.7) 70.2 (2.6) 
2 65.5 (1.8) 79.7 (1.8) 72.9 (2.9) 
6 42.9 (3.3) 51.3 (4.0) 82.2 (3.8) 
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Table 2.3 Summary of % Ag mass distribution collected at each timepoint for all forms of 
silver. Data are presented as means (SD). BDL = below detection limit. 
 
  Ag Type 















1.5 BDL 2.06 (0.03) 1.68 (0.41) 2.62 (0.38) 
2 BDL 1.75 (0.22) 1.76 (0.21) 2.85 (0.15) 




1.5 BDL 36.55 (6.76) 29.50 (0.10) 13.85 (6.40) 
2 BDL 22.97 (0.87) 33.20 (13.85) 16.35 (1.15) 





Table 2.4 One-way ANOVA test and Tukey multiple comparison test comparing the mean 
masses of strongly sorbed Ag to the outer membrane of P. aeruginosa and liberated by 50 
mM EDTA at 1.5-hour exposure, 2-hour exposure, and 6-hour exposure to EDTA. Data 
representing p values at significance level of p = 0.05 *. Results revealed insignificant 





Ag Type ANOVA Tukey Test 
  1.5 h vs 2 h 1.5 h vs 6 h 2 h vs 6 h 
Cit-AgNPs 0.005* 0.670 0.009* 0.007* 
PVP-AgNPs 0.006* >0.999 0.007* 0.010* 































Figure 2.1 Schematic representation for experimental approach showing all fractions and 
their operational extraction method.  
Free/Weakly bound 












Figure 2.2 TEM micrograph of pristine stock AgNPs placed on formvar-filmed copper 






Figure 2.3 The effect of different EDTA concentrations on bacterial growth over time 
compared to untreated controls. Mean absorbances at 600 nm for at least three replicates 
were used as to estimate changes in cell densities. Error bars represent standard deviation. 



























Figure 2.4 Confocal laser scanning microscopy (CLSM) images of fluorescent-
stained (LIVE/DEAD BacLight viability kit) P. aeruginosa cells at different 
timepoints after 50 mM EDTA treatment. (A) untreated controls; (B) cells after 2-
hour exposure to EDTA; (C) cells after 6-hour exposure to EDTA. Green 












Figure 2.5 TEM micrographs showing P. aeruginosa cells at different timepoints 
after 50 mM EDTA treatment deposited on a grid by drop-deposition method. (A) 









Figure 2.6 TEM ultra-thin sections (~90 nm thick) micrographs for P. 
aeruginosa post-stained with uranyl acetate and lead citrate at different 
timepoints after 50 mM EDTA treatment. (A) untreated controls; (B) cells 




Figure 2.7 Strongly sorbed fraction of Ag that liberated by 50 mM EDTA at 1.5-hour 
exposure, 2-hour exposure, and 6-hour exposure to EDTA. Ag masses determined by 






















Ctrl Citrate-coated PVP-coated Ag+Ag+ 
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CHAPTER 3 
THE ROLE OF SILVER NANOPARTICLES TRANSFORMATIONS IN 
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3.1 ABSTRACT 
AgNPs hold a great potential as a NPs-based therapeutic agent against multidrug resistant 
(MDR) bacterial infections. However, a comprehensive understanding to the relative role 
of particulate versus dissolved Ag in AgNPs antimicrobial activity is poorly developed. 
AgNPs undergo numerous transformations in exposure media that significantly influence 
their bioavailability, and consequently uptake and toxicity. In the current study, we exposed 
a selected Gram-negative pathogenic bacterial strain P. aeruginosa to bimetallic Au@Ag 
NPs and quantified metal distribution and Ag:Au ratio in different bacterial compartments, 
to better understand Ag complex transformations and subsequent bioavailability and 
biouptake. The result showed that concentration is a major factor governing overall NPs 
transformations and bioavailability. As indicated by relatively higher ratios in all biotic 
phase fractions at lower exposure concentration, there was greater bioavailability of Ag at 
lower concentration where dissolution seems to be the dominant process whereas less 
bioavailability was observed at higher concentration where NPs were in aggregation-
dominant state. Ag+ is enriched and preferentially adsorbed to cell surface. For all forms 
of Ag exposure, 42.8% to 54.8 % of Ag original exposure mass was detected in abiotic 
phase and was mostly in dissolved form. Weakly/strongly sorbed fractions accumulated 
35.9% to 44.7% of Ag original exposure mass. At 2.0 mg L-1 Au@Ag NPs exposure, 16.2% 
± 1.8 accumulated in the operationally defined internalized fraction. This was significantly 
greater (p =0.0066) than same fraction at 0.2 mg L-1 Au@Ag NPs exposure which 
accumulated 9.9% ± 1.1. Ag:Au molar ratios of both total abiotic phase (p >0.9999) and 
operationally defined internalized fractions (p =0.9999) were statistically equivalent to 
pristine NPs. The weight of evidence suggests that the internalized portion is a mixture of 
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depleted original Au@Ag NPs, dissolved Ag in ionic and/or re-precipitated form. The 
relative contribution of ionic versus particulate Ag in NPs-bacteria interaction are still 
poorly understood although, in this study, it seems that Ag is bioavailable in both forms 
and may interact with multi-subcellular targets in bacteria simultaneously. 
3.2 INTRODUCTION 
Engineered NPs in its simplest definition are regarded as intentionally produced particles 
with diameter between 1-100 nm in at least one dimension [254]. Particles at this size scale 
usually manifest properties that are significantly different from bulk sizes of the same 
material [274]. The novel properties of NPs have attracted researchers and scientists to 
study NPs for their potential applications in a wide range of fields including medicine, 
biomedical devices, microbiology, and cosmetics [10, 275]. Among them, the application 
of AgNPs is gaining an increasing interest. AgNPs by far are considered the most 
promising NPs in NPs-based therapeutic approach against microbial infections [276]. 
However, the relative bioavailability and biouptake of particulate versus ionic Ag, which 
is essential toward understanding AgNPs toxicity, have not been fully quantified [249, 254, 
277-279].  
 AgNPs readily undergo numerous physiochemical transformations in exposure 
media such as dissolution, agglomeration, and formation of protein corona [280, 281]. 
These transformations are dynamic and can be influenced by various factors related 
primarily to the nature of the AgNPs, exposure media compositions, as well as exposure 
conditions [280, 282]. Consequently, AgNPs transformations will influence NPs-bacteria 
interaction and cellular uptake and toxicity [283]. Therefore, it is crucial to consider AgNPs 
complex transformations in order to evaluate their bioavailability, and biouptake. 
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However, it is still very difficult to develop a comprehensive understanding to these 
processes likely due to the complexity of interaction and lack of standardized analytical 
methodologies and techniques [179, 284].  
 Recently, bi-metallic NPs have become attractive to researchers due to their higher 
functionality by combining two different metals with each featuring unique properties 
[285]. Au@Ag NPs provide the advantage of having Au core that is more stable (i.e., 
remains in particulate form) than the outer shell Ag and protected from direct interaction 
with organism and exposure media [286]. Thus, Au can be used as internal standard [179] 
to help better understand the complicated Ag transformation as well as bioavailability. 
Compared to mono-metallic NPs, more information regarding NPs-bacteria interactions 
can be obtained using Au@Ag NPs, which may enhance our understanding to 
bioavailability, bioaccumulation, and Ag solubility [286].  
 Developing an understanding to these mechanisms and cellular internalization is 
essential for NPs potential use and applications [287]. Therefore, we aim in this study to 
quantify the biouptake and bioaccumulation of nanoparticulate and ionic Ag based on the 
molar ratios of Ag to Au being taken up. The results will provide very useful insights in 
directing AgNPs optimization for therapeutic purposes. 
3.3 MATERIALS AND METHODS 
3.3.1 Silver NPs and silver shelled gold NPs 
Two different NPs suspensions were purchased from nanoComposix Inc. (San Diego, CA, 
USA): 1) 60 nm bi-metallic Au@Ag capped with sodium citrate (30 nm Au core; 15 nm 
Ag shell) at a concentration of 0.95 mg mL-1, and 2) 60 nm mono-metallic Cit-AgNPs at a 
concentration of 0.02 mg mL-1. 
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3.3.2 NPs Characterization 
Stock NPs solutions were analyzed through multimethod approach for their average 
diameter, PDI, colloidal stability, absorbance spectra, and metals (Au and Ag) 
concentrations. Detailed characterization methods were discussed previously (see section 
2.3.1). 
3.3.3 NPs toxicity testing  
The antibacterial activities of both Au@Ag and Cit-AgNPs toward P. aeruginosa (ATCC 
27853) were investigated to determine the MICs (illustrated in detail in section 2.3.2). 
Briefly, broth microdilution assay was conducted using range of concentrations (2, 5, 7, 
and 10 mg L-1), and the minimum concentration needed to completely inhibit bacterial 
growth was determined as the MIC. Using bi-metallic AgNPs with Au core might affect 
the antibacterial activity of Ag. To account for that, mono-metallic Cit-AgNPs of 
comparable physiochemical characteristics were investigated and their antimicrobial 
activities were compared.  
3.3.4 Bacterial exposure to NPs  
Bacterial cultures grown under similar conditions (see section 2.3.4), harvested, and 
resuspended in fresh TSB media. To investigate the concentration-dependent 
transformations and biouptake [178], bacterial suspensions were exposed to two 10-fold 
different concentrations of Au@Ag in separate containers, 2.0 and 0.2 mg L-1 in dark for 
24 hours.  Additionally, bacterial suspensions exposed to 2.0 mg L-1 of mono-metallic 
AgNPs of comparable diameter and coating (as a control for the effect of Au core), and 
AgNO3 (as a positive control for the effect of dissolved Ag) under similar conditions.  
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3.3.5 Bacterial microscopy assessment 
Samples prepared and examined under CLSM and TEM to assess cell viability and 
structural changes. Detailed sample preparations were discussed previously (see section 
2.3.3.2 and 2.3.3.3). Samples collected before- and after- periplasm removal and then 
stained with LIVE/DEAD BacLight bacterial viability kit. At least five randomly taken 
images obtained with CLSM and cell counts per FOV (FOV = 238x238 µm) were 
quantified in each acquired micrograph using ImageJ software. Samples mean cell counts 
for both before- and after- periplasm removal were statistically compared using paired t-
test for each exposure type. Mean cell counts were also compared between different NPs 
exposure at each sampling timepoint using paired t-test to further investigate the effect of 
Au core in AgNPs toxicity. Additionally, ultra-thin sections (~90 nm thick) were prepared 
as previously illustrated (section 2.3.3.3) and were analyzed with TEM. 
3.3.6 Bacterial exposure to EDTA and different fractions quantification 
Exposures were performed for 24 hours in triplicate at a concentration of 2.0 mg L-1 for 
Cit-AgNPs and AgNO3 exposure types whereas for Au@Ag NPs exposure were performed 
at concentrations of 2.0 mg L-1 and 0.2 mg L-1. When exposure time was completed, 
exposed bacteria were washed three times by centrifugation under similar conditions. 
Supernatants of these initial washes representing abiotic phase (i.e., aqueous fraction) were 
accumulated. Each pellet was resuspended in PBS and divided into two separate tubes of 
equal volumes. First group of tubes were further washed with PBS three times, the 
supernatants of these washes, representing weakly bound fraction, were accumulated. 
Pellets then resuspended in PBS and this fraction represent both strongly sorbed and 
internalized fractions combined. The other group of tubes were treated with 50 mM EDTA 
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and bacterial suspensions were incubated under similar growth conditions. Two hours post 
EDTA treatment, suspensions were washed three times by centrifugation under same 
conditions. Supernatants of post-EDTA-treatment washes, representing cellular external 
fractions (weakly bound and strongly sorbed), were accumulated (Figure 3.1). All 
separated fractions were sampled, digested, and analyzed for their total metals content 
(illustrated in detail in section 2.3.3.4). Abiotic phase was analyzed for both total and 
dissolved metals content after separating particles from dissolved forms for both Ag and 
Au using centrifugal ultrafiltration devices (Pall Corporation, Microsep Advance with 
3kDa omega) and centrifuged at 4000 rpm for 30 minutes at 25°C. Particle form was 
calculated by the difference between these two fractions. Moles and molar ratios were 
calculated from Ag and Au masses obtained by ICPMS. Results were statistically analyzed 
using ANOVA (p < 0.05) and subsequently Tukey multiple comparison test where 
ANOVA was significant. 
3.4 RESULTS  
3.4.1 NPs characterization 
Absorption spectra, size distribution and TEM images of pristine NPs suspensions are 
shown in Figure 3.2 and 3.3. Characterization resulted in UV-vis absorption peaks at 433.0 
nm ± 1.0 and 439.0 nm ± 1.5, average hydrodynamic sizes were 63.4 nm ± 1.0 and 66.5 
nm ± 1.8, PDIs were 0.2 ± 0.01 and 0.1 ± 0.01 for Au@Ag NPs and Cit-AgNPs, 
respectively (Table 3.1). Total metal concentrations for pristine Au@Ag NPs resulted in 
an Ag:Au mean mass ratio of 2.8 ± 0.3 that corresponds to a molar ratio of 5.1 ± 0.6. Stock 
NPs characterizations provided by manufacturer indicated that Ag:Au mean mass ratio is 
3.0 that corresponds to 5.4 molar ratio. 
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3.4.2 Antibacterial activities 
The antimicrobial activities of Au@Ag NPs and Cit-AgNPs, with average diameters of ~ 
60.0 nm, toward P. aeruginosa were determined by the standard microdilution method. 
The obtained results suggested identical antimicrobial potency of > 10.0 mg L-1 for both 
NPs types. To avoid the antibacterial effect of NPs for this study, 2.0 mg L-1 and  
0.2 mg L-1 were selected as the sublethal doses to be investigated for their interactions. 
3.4.3 Bacterial viability and structural changes assessment 
Figure 3.4 shows CLSM micrographs of P. aeruginosa before- and after- periplasm 
removal. Samples were stained with LIVE/DEAD fluorescent viability kit which visualizes 
live bacterial cells as green or red otherwise as a function of cell membrane integrity. 
However, all visualized cells (for both NPs exposure at both sampling timepoints) 
fluoresced green indicating bacterial integrity in all samples. As summarized in Table 3.2, 
the mean numbers of viable cell counts were not significantly different (p = 0.2105) for 
cells exposed to Au@Ag NPs before- and after- periplasm removal at values of 1493 ± 109 
and 1449 ± 157 cells/ FOV, respectively. Similarly, statistically insignificant difference (p 
= 0.6033) was found in the mean numbers of viable cell counts before- (1361 ± 189 
cells/FOV) and after- (1475 ± 123 cells/ FOV) periplasm removal in group exposed to Cit-
AgNPs. Mean number of viable cell counts in bimetallic Au@Ag NPs-exposed cells was 
not significantly different from mean number of viable cell counts in group exposed to 
monometallic AgNPs at both sampling timepoints (p = 0.3046 before periplasm removal 
versus p = 0.8313 after periplasm removal). No structural changes were detected in the 
TEM images (Figure 3.5).  
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3.4.4 Metal accumulation 
3.4.4.1 Quantification of metals distribution 
In all exposure types, fractions were defined operationally based on our experimental 
approach and extraction methodology as follows (Figure 3.1). Fraction separated by initial 
PBS washes were referred to as abiotic phase (i.e., aqueous fraction) whereas pellets were 
referred to as biotic phase fraction. The biotic phase further fractionated into external 
cellular fractions (either weakly or strongly sorbed to the cell surface) and internalized 
fraction. Fraction separated by second PBS washes were referred to as weakly bound 
fraction while pellets of these washes were referred to as strongly sorbed and internalized 
fractions combined. The EDTA-extracted fraction here referred to as strongly sorbed and 
internalized fractions combined (i.e., cellular external fractions) whereas metal 
accumulated in the pellets after periplasm removal were defined as internalized fractions. 
Molar concentrations were calculated for all fractions in both biotic and abiotic 
phases (Table 3.3). For all forms of Ag exposure, nearly one-half (the highest accumulating 
fraction) of the total added Ag accumulated in the aqueous fraction (i.e., abiotic phase) 
ranging from 42.8% to 54.8 %. The detected Ag in this fraction was mostly in the dissolved 
form ranging from 46.0% to 80.0% for all forms of Ag. The weakly bound fraction was 
the highest in 2.0 mg L-1 Au@Ag NPs exposure (42.4% ± 4.5), followed by 0.2 mg L-1 
Au@Ag NPs exposure (33.9% ± 3.6), Cit-AgNPs exposure (33.0% ± 3.2), and Ag+ 
exposure (26.2% ± 1.9). On the other hand, the external cellular fractions (weakly bound 
and strongly bound), that were liberated with EDTA (i.e., periplasm removal), and 
subsequently washed off with PBS, were ranging from 35.9% to 44.7% for all forms of Ag 
exposure. Ag percentage accumulation in the operationally defined internalized fraction 
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was significantly greater (p =0.0066) in the 2.0 mg L-1 Au@Ag NPs exposure at a mean 
percentage of 16.2% ± 1.8 compared to 9.9% ± 1.1 for 0.2 mg L-1 Au@Ag NPs exposure 
(Table 3.4). However, the highest percentage of Ag accumulation in the operationally 
defined internalized fraction was detected in Ag+ exposure at a value of 31.4% from the 
original exposure concentration compared to all other forms of Ag exposure (Figure 3.6). 
Similarly, Au accumulated preferentially in the abiotic phase at percentages of 
23.1% ± 2.7 and 42.0% ± 2.2 for the 2.0 mg L-1 Au@Ag NPs exposure and 0.2 mg L-1 
Au@Ag NPs exposure, respectively. Percentage accumulation was significantly greater (p 
=0.0007) in the lower exposure concentration. On the other hand, the Au accumulated in 
the operationally defined internalized fraction was significantly greater (p =0.0008) in the 
2.0 mg L-1 Au@Ag NPs exposure at an accumulation percentage of 13.2% ± 1.2 compared 
to 6.6% ± 0.4 in the 0.2 mg L-1 Au@Ag NPs exposure. Furthermore, cellular external 
fraction (operationally defined as weakly bound and strongly sorbed fractions combined) 
accumulated significantly higher (p =0.0021) percentage of Au in the 2.0 mg L-1 Au@Ag 
NPs exposure at 21.8% ± 2.8 versus 10.1% ± 0.5 in the 0.2 mg L-1 Au@Ag NPs exposure. 
Most aqueous phase Au remained in particulate form (Figure 3.7), 98.3% in the 2.0 
mg L-1 Au@Ag NPs exposure and 96.2% in the 0.2 mg L-1 Au@Ag NPs exposure. 
Internalized Au percentages detected were greater for higher concentration exposure at a 
value of 13.2% ± 1.2 compared to 6.6% ± 0.4 in lower exposure. Cellular external fraction 
of Au was 10.1% ± 0.5 in the 0.2 mg L-1 Au@Ag NPs exposure while it was 21.8% ± 2.8 
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3.4.4.2 Metallic molar ratios 
For all biotic phase fractions, concentration-dependent accumulations of Ag were observed 
with significantly greater Ag:Au molar ratios at 0.2 mg L-1 Au@Ag NPs exposure (Table 
3.5) before- and after- periplasm removal except for internalized fraction (p = 0.4726) 
compared to 2.0 mg L-1 Au@Ag NPs exposure. In contrast, significantly lower Ag:Au 
molar ratios (p = 0.0106) were observed in the total abiotic phase (i.e., aqueous fraction) 
fraction at 0.2 mg L-1 Au@Ag NPs exposure. Ag:Au molar ratios in the total abiotic phase 
were relatively equal to the pristine molar ratio (5.1 ± 0.6) at both concentrations. However, 
significantly greater ratios were observed in the dissolved fraction of the abiotic phase at 
values of 562.1 ± 92.1 (p <0.0001) and 125.9 ± 12.2 (p <0.0001) for higher and lower 
exposure, respectively (Table 3.5). Before periplasm removal, significant differences were 
only detected at 0.2 mg L-1 Au@Ag NPs exposure (Figure 3.8) in both weakly bound 
fraction (p <0.0001) and the combined strongly sorbed and internalized fraction (p 
<0.0001). Whereas after periplasm removal, Ag:Au ratios were not significantly different 
from pristine NPs ratio in all biotic phase fractions at both exposure concentrations with 
mean values ranging from 6.9 to 18.2.  
3.4.4.3 Mass Balance 
Mass balance calculations were conducted for both Ag and Au to calculate the recovery 
rates in all types of exposure suspensions (Table 3.6). The recovery rates of Ag before 
periplasm removal (Figure 3.9) were 106.6% ± 7.9 in the 2.0 mg L-1 Au@Ag NPs exposure, 
88.1% ± 8.1 in the 0.2 mg L-1 Au@Ag NPs exposure, 82.7% ± 2.7 in Cit-AgNPs exposure, 
and 108.1% ± 5.1 in Ag+ exposure. Whereas after periplasm removal (Figure 3.10), they 
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were 115.7% ± 6.0 in the 2.0 mg L-1 Au@Ag NPs exposure, 97.6% ± 19.2 in the 0.2 mg 
L-1 Au@Ag NPs exposure, 98.4% ± 4.5 for Cit-AgNPs, and 116.4% ± 15.1 for Ag+. 
 On the other hand, Au exhibited higher rates of loss from the system. The maximum 
recovery rate for Au was 58.2% ± 10.5 in the 2.0 mg L-1 Au@Ag NPs exposure followed 
by 52.0% ± 0.2 in the 0.2 mg L-1 Au@Ag NPs exposure. Lower recovery rates were 
achieved before periplasm removal at values of 30.2% ± 1.0 and 37.5% ± 2.2 for the 2.0 
mg L-1 Au@Ag NPs exposure and 0.2 mg L-1 Au@Ag NPs exposure, respectively. 
3.5 DISCUSSION 
Similar antibacterial activities (i.e., MICs) for bimetallic Au@Ag NPs and monometallic 
Cit-AgNPs, and insignificant differences in mean viable cell counts between Au@Ag NPs-
exposed and Cit-AgNPs-exposed groups suggested similar toxicities and negligible effect 
of Au core in AgNPs behavior. Therefore, we assume that inferences from Au@Ag NPs 
interaction with P. aeruginosa could be generalized to monometallic AgNPs of comparable 
physiochemical characteristics. Furthermore, a recent study [179] and our metallic 
dissolution data (Table 3.3) supports our assumption on relying on the Au as an internal 
standard that mainly remained in particulate form throughout the interaction with bacteria. 
However, Au recovery rates were lower than those for Ag which might be attributed to the 
relatively greater tendency of Au to adhere and be lost to the container walls.  
Concentration-dependent dissolution (Figure 3.7) observed is suggesting that 
Au@Ag NPs are undergoing dynamic changes in the exposure interface which eventually 
influence their bioavailability and biouptake [288-291]. Dissolution is likely the dominant 
process occurring at the lower exposure concentration [178, 179], whereas aggregation and 
deposition seem to be the dominant processes occurring at the higher exposure 
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concentration which reduced Au@Ag NPs bioavailability to a certain degree [292, 293]. 
This is indicated by lower Ag:Au molar ratios (Figure 3.8) at higher exposure concentration 
compared to lower exposure concentration consistently in all biotic phase fractions (i.e., 
significant in all biotic phase fractions except for internalized (Table 3.5)) accompanied by 
relatively higher ratios in the abiotic phase (i.e., unbound state). Supported by dissolution 
data (Figure 3.7), the massive increase of Ag:Au at surface bound fraction (i.e., in the 
weakly bound before periplasm removal and to a lesser extent in the combined weakly 
bound and strongly sorbed fraction after periplasm removal) (Figure 3.8), suggests that 
dissolved Ag+ is preferentially binding to cell surface whereas NPs are more bioavailable 
for internalization, however, this is not necessarily true. 
 Ag:Au ratios in the operationally defined internalized fractions were relatively 
equal to the pristine Au@Ag NPs ratio suggesting same amount of Ag and Au being taken 
up by the organism. Because NPs are dissolving and ionic Ag is enriched on the cell 
surface, it is quite unlikely that biouptake is solely for the original Au@Ag NPs, and Ag 
ions are completely excluded from internalization. However, the most likely explanation 
is that the internalized portion of Ag is the summation of the complex Ag transformations 
and biouptake. In fact, the weight of evidence suggests that the internalized fraction could 
be a mixture of completely or partially depleted Au@Ag NPs (with reduced Ag), ionic or 
re-precipitated Ag+ (in form of Ag-Cl complexes or secondary NPs), and the sum of that is 
coincidentally of an equivalent Ag:Au ratio of the pristine Au@Ag NPs. Therefore, Ag in 
particulate and ionic forms are both bioavailable and taken up by P. aeruginosa. This 
theory is further supported by other studies conducted to evaluate AgNPs transformation 
and bioavailability, in which both ionic and particulate Ag found to be bioavailable [294, 
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295]. This result suggests that AgNPs interact with multiple cellular targets in bacteria 
simultaneously [45]. 
 Although AgNPs bioavailability compared to Ag+ has been extensively studied, 
controversies still abound concerning the relative bioavailability of ions versus particles 
[172]. For example, in recent studies, bioaccumulation and biouptake was attributed to the 
particulate form of Ag rather than to dissolved Ag+ in certain organisms [172, 294, 296]. 
In contrast, numerous studies that have been conducted attributed biouptake mainly to 
dissolved Ag [297-299]. However, distinguishing Ag ions from NPs in different bacterial 
compartment remains complicated because of the limitations associated with current 
analytical techniques and the lack of valid standardized methodology [179].  
 
 67  
Table 3.1 Summary of Au@Ag NPs and AgNPs physiochemical characterization data for 




Sample UV-vis absorbance  DLS 
 Peak Position (nm) 
 
Diameter (nm) PDI 
Au@Ag NPs 
 439.0 (1.5) 
 
66.5 (1.8)  0.1 (0.01) 
Cit-AgNPs 433.0 (1.0) 
 
63.4 (1.0)  0.2 (0.01) 
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Table 3.2 Cell counts of CLSM images for Au@Ag NPs-exposed and Cit-AgNPs-exposed 
cells before- and after- periplasm removal along with t-test results of statistical significance 
of difference between mean values at p <0.05*. Data presented as mean (SD). FOV= Field 



























p value 0.3046  0.8318   
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Table 3.3 Metallic molar concentration (µmol) of Ag and Au in all fractions for each type 
of exposure. 
  
 Biotic phase mole concentration (µmol) 
mean (SD) 
 
  Au@Ag NPs Ag+ Cit-AgNPs 
  2.0 mg L-1  0.2 mg L-1   






























































































  Au@Ag NPs Ag+ Cit-AgNPs 
  2.0 mg L-1  0.2 mg L-1   
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Table 3.4 Percentage mean mass distribution (%) of Ag and Au of initially added mass in 
all fractions for each type of exposure. 
  
  
Biotic phase percentage mean mass distribution (%) 
mean (SD) 
  Au@Ag NPs Ag+ Cit-AgNPs 
  2.0 mg L-1  0.2 mg L-1   
























































































Abiotic phase percentage mass distribution (%) 
mean (SD) 
   Au@Ag NPs Ag
+ Cit-AgNPs 
  2.0 mg L-1  0.2 mg L-1   
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Table 3.5 Summary of molar ratios and statistical significance data. Tukey multiple 
comparison test comparing mean molar ratio of each fraction in both exposure 
concentrations to pristine Au@Ag NPs molar ratio of 5.1 (0.6), and t-test results for 
concentration-dependent difference in mean molar ratios in each fraction at significance 




 Biotic phase 
  Molar ratio  Tukey t-test 


















































(2.1)  >0.9999 0.0617 0.0024* 
Internalized 6.9  (2.4) 
8.3  
(1.9)  0.9999 0.9894 0.4726 
   Abiotic phase   
  Molar ratio  Tukey t-test 












(12.2)  <0.0001* <0.0001* 0.0012* 
Particle 6.2  (2.2) 
2.0  
(0.3)  >0.9999 0.9911 0.0306* 
Total 13.1 (1.7) 
7.5  
(1.3)  >0.9999 0.9981 0.0106* 
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Table 3.6 Recovery rates % for all types of Ag before- and after- periplasm removal 
obtained by ICPMS. Data presented as the mean percent recovery (SD) from aqueous 












 After periplasm 
removal (%) 
Mean (SD) 
2.0 mg L-1  
Cit-AgNPs 20.0 82.7 (2.7) 
 
98.4 (4.5) 
Ag+ 2.0 mg L-1 20.0 108.1 (5.1) 
 
116.4 (15.1) 
Ag in 2.0 mg L-1 
Au@Ag 15.0 106.6 (7.9) 
 
115.7 (6.0) 
Ag in 0.2 mg L-1 
Au@Ag 1.5 88.1 (8.1) 
 
97.6 (19.2) 
Au in 2.0 mg L-1 
Au@Ag 5.0 30.2 (1.0) 
 
58.2 (10.5) 
Au in 0.2 mg L-1 











































Figure 3.1 Schematic representation for experimental approach showing all fractions and 














































Figure 3.2 Characterization of stock bimetallic Au@Ag NPs. (A) TEM image (obtained 
from manufacturer nanoComposix), (B) UV-Vis spectra obtained by UV-Vis, (C) size 


































































Figure 3.3 Characterization of stock Cit-AgNPs. (A) TEM image (obtained from 
manufacturer nanoComposix), (B) UV-Vis spectra obtained by UV-Vis, (C) size 
distribution obtained by DLS. 
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Before periplasm removal   After periplasm removal 
 












Before periplasm removal   After periplasm removal 
 
Figure 3.4 Confocal laser scanning microscopy (CLSM) images of fluorescent-stained 
(LIVE/DEAD BacLight viability kit) P. aeruginosa cells before- and after- periplasm 
removal. (A) exposed to Au@Ag NPs; (B) exposed to Cit-AgNPs; (A1 and B1) before 
periplasm removal; (A2 and B2) after periplasm removal. Green fluorescence indicates 
cells with intact membranes (Live cells). There were no significant differences between 
cell counts before and after periplasm removal in both exposures at significance level p 






 77  











Before periplasm removal   After periplasm removal 
 












Before periplasm removal   After periplasm removal 
 
Figure 3.5 TEM ultra-thin sections (~90 nm thick) micrographs of P. aeruginosa post-
stained with uranyl acetate and lead citrate.  (A) exposed to Au@Ag NPs; (B) exposed to 






 78  
 
 
Figure 3.6 Metals mass distribution after periplasm removal presented as 100% stacked 
bar chart. The sum of dissolved and particulate form constitutes the total metal content in 
the abiotic phase. The sum of dissolved and particulate forms represents the total metal 
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Figure 3.7 Total dissolved and particle form of metals in percent (%) of total mass detected 
in abiotic phase. 
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Figure 3.8 Ag:Au molar ratios in bacterial different fractions. The stock Au@Ag NPs 
Ag:Au ratio is indicated as a straight horizontal line at a value of 5.1. Each bar represents 
the average of three replicates. Error bars represent standard deviation. The asterisk denotes 
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Figure 3.9 Percentage of metals mass distribution before periplasm removal. The original 
exposure concentration percent is indicated as a straight horizontal line at a value of 100%. 
Each bar represents the average of three replicates. Error bars represent standard deviation. 
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Figure 3.10 Percentage of metals mass distribution after periplasm removal. The original 
exposure concentration percent is indicated as a straight horizontal line at a value of 100%. 
Each bar represents the average of three replicates. Error bars represent standard deviation. 
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Bacteria are monocellular yet highly sophisticated and adaptable microorganisms. Their 
remarkable capacity to adapt stresses and develop resistance against antibiotics resulted in 
the emergence of MDR. Multiple bacterial mechanisms may contribute to the development 
of resistance against conventional antimicrobial agents such as alteration in drug target and 
modifying membrane fluidity and permeability. Although MDR is challenging to treat, the 
rapidly growing field of nanotechnology could be the solution through utilizing NPs 
tunable properties. Materials at nanoscale can acquire novel properties as a result of 
quantum size effect and high specific surface area. 
 Nanotechnology offers a wide range of revolutionary applications in variety of 
scientific fields. Particularly, AgNPs were the most studied NPs as a potent broad-spectrum 
antimicrobial agent that bacteria are less likely to develop resistance against. However, 
interaction between AgNPs and bacteria is complex and yet to be fully elucidated. 
Physiochemical properties of AgNPs and exposure media composition determine the 
ultimate outcome of the interactions. Developing an understanding to the mechanisms of 
interaction and the role of NPs transformations in AgNPs antimicrobial activity is essential 
for their potential utilization in medical field. However, this is limited by the combination 
of the complexity of exposure systems, lack of standardized analytical methods and 
limitations of current analytical techniques. 
 In this work, a novel method was developed and validated to separate and quantify 
AgNPs distribution in different bacterial compartments (i.e., internalized, strongly sorbed, 
and weakly bound to the external surface of the cell). EDTA, a metal chelator, was applied 
to specifically binds to the divalent cations that stabilize bacterial outer membrane. 
Therefore, at the optimal treatment conditions, EDTA will only remove the bacterial 
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periplasm (i.e., outer cell membrane, cell wall, surface-sorbed-NPs, and NPs contained 
within this space) of Gram-negative bacterium P. aeruginosa, without significantly 
influencing cells inner membrane integrity. 
 The validation process was conducted using multimethod approach to falsify our 
hypothesis of EDTA effect under appropriate treatment condition. Treating cells with 50 
mM EDTA for two hours consistently suggested that our proposed method is accurately 
differentiating and approximating the amount of Ag accumulated over external bacterial 
surface and/or internalized into bacterial cytoplasm. However, multiple Ag species could 
accumulate within each fraction. 
 AgNPs readily undergo dynamic physiochemical transformation and speciation in 
exposure media. The capability of currently available analytical techniques to differentiate 
the relative role of AgNPs and Ag+ in biouptake and bioaccumulation is limited. As a result, 
it is still not very clear which Ag species is more bioavailable. To better assess that, the 
previously validated method was applied to quantify Ag:Au distribution after exposing 
bacterial strain to core-shell NPs, Au@Ag. The Au core in the bimetallic Au@Ag NPs was 
used as an internal standard due to its relatively higher stability (i.e., remains in particulate 
form throughout exposure) compared to Ag shell. 
 Data obtained suggested a remarkable influence of concentration on AgNPs 
transformations and bioavailability. At lower concentrations, Ag was in a dissolution-
dominant process and relatively more bioavailable to be taken up by the microorganism. 
AgNPs at higher concentrations tend to aggregate and deposit at the bottom of the exposure 
tube. As particles get larger, their specific surface area gets smaller. Therefore, deposited 
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particles lower bioavailability might be attributed to that NPs aggregates tend to have 
smaller specific surface area and deposit away from direct interaction with the organism. 
 Bacterial cell external surface was Ag-enriched mainly with dissolved Ag whereas 
various Ag species appeared to make their way to the inside of bacterial cytoplasm. The 
weight of evidence in this work suggests multiple cellular targets of AgNPs and other Ag 
species that resulted from AgNPs transformations in exposure system. This multi-target 
action of AgNPs further support the view of AgNPs promising potential in overcoming 
MDR bacterial infections. However, uncertainty regarding AgNPs cytotoxicity and the 
exact mechanism of action remains a major impediment to scientific progress in AgNPs 
applications. 
 While this chemical extraction method was successfully validated for P. 
aeruginosa exposed to AgNPs, applying it to another microorganism or using another NPs 
may require further validation. We recommend applying it to a range of Gram-negative 
bacteria and NPs with different physiochemical characteristics to increase its external 
validity. Furthermore, applying the method in another exposure system that simulates the 
complex composition of human body will further improve its applicability and 
generalizability.
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